CompanyDrug

BeiGene’s Tislelizumab Receives 11th NMPA Filing for First-Line Esophageal Cancer

CompanyDrug

Innovent Biologics Doses First Patient in Australia Trial for PD-1/IL-2 Bispecific Antibody IBI363

CompanyDeals

Lee’s Pharma Expands Global Rights to Windtree’s KL4 Surfactant Products

CompanyDeals

Genetron Holdings Receives Buyout Offer from CEO Wang Sizhen at USD 1.36 per ADS

DrugLegal / IP

Supreme People’s Court Rules Against Chugai in China’s First Patent Linkage Case

Company

Ascletis Pharma’s H1 2022 Revenue Rises 4.8% on R&D and Product Sales Growth

CompanyDrug

Viatris Pharmaceuticals’ HIV/AIDS Drug Prioritized for CDE Review

CompanyDeals

Hansoh Pharma Licenses GHDDI’s GDI-4405 for Global Development in COVID-19

CompanyDrug

Anhui Anke’s HK010 Bispecific Antibody Receives NMPA Review for Cancer Trials

CompanyDeals

China-Based Firms Form Partnership to Advance Cell and Gene Therapy Ecosystem

CompanyDeals

BIOPSEE Series A+ Financing Confocal Microendoscope

CompanyDrug

CSPC Pharmaceutical’s DBPR108 Hits Endpoints in Type 2 Diabetes Trials